4/12
08:01 am
celc
Celcuity Inc. (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $24.00 price target on the stock.
Medium
Report
Celcuity Inc. (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $24.00 price target on the stock.
4/4
07:19 am
celc
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences [Yahoo! Finance]
Low
Report
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences [Yahoo! Finance]
4/4
07:05 am
celc
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
Low
Report
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
4/3
07:09 am
celc
Celcuity Gains 12%, Insider Trades Reap Benefit [Yahoo! Finance]
Low
Report
Celcuity Gains 12%, Insider Trades Reap Benefit [Yahoo! Finance]
4/1
01:50 pm
celc
Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/28
08:07 am
celc
Celcuity Inc. (NASDAQ: CELC) had its price target raised by analysts at Needham & Company LLC from $23.00 to $24.00. They now have a "buy" rating on the stock.
High
Report
Celcuity Inc. (NASDAQ: CELC) had its price target raised by analysts at Needham & Company LLC from $23.00 to $24.00. They now have a "buy" rating on the stock.
3/28
08:07 am
celc
Celcuity Inc. (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
High
Report
Celcuity Inc. (NASDAQ: CELC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
3/27
04:28 pm
celc
Celcuity Non-GAAP EPS of -$0.61 beats by $0.14 [Seeking Alpha]
High
Report
Celcuity Non-GAAP EPS of -$0.61 beats by $0.14 [Seeking Alpha]
3/27
04:09 pm
celc
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
High
Report
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/27
04:01 pm
celc
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
High
Report
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
3/26
09:19 am
celc
InnoSIGN Appoints Eric Lindquist Chief Executive Officer [Yahoo! Finance]
Medium
Report
InnoSIGN Appoints Eric Lindquist Chief Executive Officer [Yahoo! Finance]
3/21
12:33 pm
celc
Why Celcuity (CELC) Might Surprise This Earnings Season [Yahoo! Finance]
Low
Report
Why Celcuity (CELC) Might Surprise This Earnings Season [Yahoo! Finance]
3/20
07:23 am
celc
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call [Yahoo! Finance]
Low
Report
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call [Yahoo! Finance]
3/20
07:05 am
celc
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
Low
Report
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
3/6
07:05 am
celc
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
Low
Report
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
2/28
07:22 am
celc
Celcuity to Participate in Cowen's 44th Annual Health Care Conference [Yahoo! Finance]
Neutral
Report
Celcuity to Participate in Cowen's 44th Annual Health Care Conference [Yahoo! Finance]
2/28
07:05 am
celc
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference
Low
Report
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference
2/22
04:24 pm
celc
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer [Yahoo! Finance]
Low
Report
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer [Yahoo! Finance]
2/22
04:05 pm
celc
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
Low
Report
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
2/22
07:11 am
celc
Celcuity Inc. (NASDAQ: CELC) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $40.00 price target on the stock.
Medium
Report
Celcuity Inc. (NASDAQ: CELC) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $40.00 price target on the stock.
2/20
07:21 am
celc
Celcuity Appoints Eldon Mayer as Chief Commercial Officer [Yahoo! Finance]
Medium
Report
Celcuity Appoints Eldon Mayer as Chief Commercial Officer [Yahoo! Finance]
2/20
07:05 am
celc
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
Medium
Report
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
1/22
07:45 am
celc
Celcuity Inc. (NASDAQ:CELC) has caught the attention of institutional investors who hold a sizeable 33% stake [Yahoo! Finance]
Low
Report
Celcuity Inc. (NASDAQ:CELC) has caught the attention of institutional investors who hold a sizeable 33% stake [Yahoo! Finance]